Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3 edit. American Psychiatric Assoc., Washington, D.C. 1987, revised (DSM-III R.)1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3 edit. American Psychiatric Assoc., WashingtonD.C. 1987, revised (DSM-III R.)
   Google Scholar
• Clancy J., Noyes R., Hoenk P., Slymen D. Secondary depression in anxiety neurosis. J. Nerv. Ment. Dis. 1978; 166: 846–8502. Clancy J., Noyes R., Hoenk P., Slymen D. Secondary depression in anxiety neurosis. J. Nerv. Ment. Dis. 1978; 166: 846–850
   PubMed Web of Science ®Google Scholar
• Covi L., Lipman R. S. Primary depression or primary anxiety'? A possible psychometric approach to a diagnostic dilemma. Clin. Neuropharmacol. 1984; 7(Suppl. 1)924–9253. Covi L., Lipman R. S. Primary depression or primary anxiety'? A possible psychometric approach to a diagnostic dilemma. Clin. Neuropharmacol. 1984; 7(Suppl. 1)924–925
   Google Scholar
• Faravelli C., Guerrini degl'Innocenti B., Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr. Scand. 1989; 79: 308–3124. Faravelli C., Guerrini degl'Innocenti B., Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr. Scand. 1989; 79: 308–312
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. Ba J. Med. Psychol. 1959; 32: 50–555. Hamilton M. The assessment of anxiety states by rating. Ba J. Med. Psychol. 1959; 32: 50–55
   PubMed Web of Science ®Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Ba J. Soc. Clin. Psychol. 1976; 6: 278–2966. Hamilton M. Development of a rating scale for primary depressive illness. Ba J. Soc. Clin. Psychol. 1976; 6: 278–296
   Google Scholar
• Itil T. M., Menon G. M., Itil K. Z. Computer EEG drug data base in psychopharmacology and in drug development. Psychopharmacol. Bull. 1982; 18: 165–1727. Itil T. M., Menon G. M., Itil K. Z. Computer EEG drug data base in psychopharmacology and in drug development. Psychopharmacol. Bull. 1982; 18: 165–172
   PubMedGoogle Scholar
• Pariante F., Caddeo S., Ecari U. Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms. Curr. Med. Res. Opin. 1989; 11: 543–5498. Pariante F., Caddeo S., Ecari U. Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms. Curr. Med. Res. Opin. 1989; 11: 543–549
   PubMed Web of Science ®Google Scholar
• Pinder R. M. The benefits and risks of antidepressant drugs. Hum. Psyrhopharmacol. 1988; 3: 73–869. Pinder R. M. The benefits and risks of antidepressant drugs. Hum. Psyrhopharmacol. 1988; 3: 73–86
   Google Scholar
• Reich J. M. The epidemiology of anxiety. J. Nerv. Ment. Dis. 1986; 174: 129–13610. Reich J. M. The epidemiology of anxiety. J. Nerv. Ment. Dis. 1986; 174: 129–136
   PubMed Web of Science ®Google Scholar
• Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry 1984; 41: 949–95811. Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Roncari G. C., Cantutti A., Ecari U., Mastrantoni M. A controlled clinical study on etizolam (Pasaden) in patients suffering from generalized anxiety disorders. Clin. Trials J. 1989; 26: 248–25512. Roncari G. C., Cantutti A., Ecari U., Mastrantoni M. A controlled clinical study on etizolam (Pasaden) in patients suffering from generalized anxiety disorders. Clin. Trials J. 1989; 26: 248–255
   Google Scholar
• Rudorfer M. V., Potter W. Z. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 1989; 37: 713–73813. Rudorfer M. V., Potter W. Z. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 1989; 37: 713–738
   PubMed Web of Science ®Google Scholar
• Saito M. Clinical significance and methodological problems of quantitative electro-encephalography in the discovery and the prediction of psychotropic properties of a newly developed substance. Proceedings of the 10th Congress of Collegium Internationale Neuro-Psychopharmacologicum, P. Deniker, C. Radouco-Thomas, V. Villeneuve. Pergamon, London 1978; 1191–120214. Saito M. Clinical significance and methodological problems of quantitative electro-encephalography in the discovery and the prediction of psychotropic properties of a newly developed substance. Proceedings of the 10th Congress of Collegium Internationale Neuro-Psychopharmacologicum, P. Deniker, C. Radouco-Thomas, V. Villeneuve. Pergamon, London 1978; 1191–1202
   Google Scholar
• Setoguchi M., Takahara S., Nakajima A., Tsumagari T., Takigawa Y. Effects of etizolam on the metabolism of biogenic amines in brain. Arzneim. Forsch. 1978; 28: 1165–116915. Setoguchi M., Takahara S., Nakajima A., Tsumagari T., Takigawa Y. Effects of etizolam on the metabolism of biogenic amines in brain. Arzneim. Forsch. 1978; 28: 1165–1169
   PubMed Web of Science ®Google Scholar
• Stavrakaki C., Vargo B. The relationship of anxiety and depression: a review of the literature. Br J. Psychiatrv. 1986; 149: 7–1616. Stavrakaki C., Vargo B. The relationship of anxiety and depression: a review of the literature. Br J. Psychiatrv. 1986; 149: 7–16
   PubMed Web of Science ®Google Scholar
• Tsumagari T., Nakajima A., Fukuda T., Shuto S., Kenjo T., Morimoto Y., Takigawa Y. Pharmacological properties of Y-7131: a new anti-anxiety drug. Armeim. Forsch. 1978; 28: 1158–116517. Tsumagari T., Nakajima A., Fukuda T., Shuto S., Kenjo T., Morimoto Y., Takigawa Y. Pharmacological properties of Y-7131: a new anti-anxiety drug. Armeim. Forsch. 1978; 28: 1158–1165
   PubMed Web of Science ®Google Scholar
• Weissman M. M. The epidemiology of anxiety disorders. Rates, risks and familial patterns. J. Psychiata Res. 1988; 22(Suppl. 1)99–11418. Weissman M. M. The epidemiology of anxiety disorders. Rates, risks and familial patterns. J. Psychiata Res. 1988; 22(Suppl. 1)99–114
   PubMedGoogle Scholar